Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation

Biomarker tests in lung cancer have been traditionally ordered by the treating oncologist upon confirmation of an appropriate pathological diagnosis. The delay this introduces prolongs yet further what is already a complex, multi-stage, pre-treatment pathway and delays the start of first-line system...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosney, J.R., Paz-Ares, L., Jänne, P., Kerr, K.M., Leighl, N.B., Lozano, M.D., Malapelle, U., Mok, T., Sheffield, B.S., Tufman, A., Wistuba, I.I., Peters, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485396/
https://www.ncbi.nlm.nih.gov/pubmed/37356358
http://dx.doi.org/10.1016/j.esmoop.2023.101587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485396/
https://www.ncbi.nlm.nih.gov/pubmed/37356358
http://dx.doi.org/10.1016/j.esmoop.2023.101587

Ejemplares similares